TSMC, the company that manufactures most of the world's advanced computer chips, reported a profit of about US$22 billion for the second quarter of 2026. That was a record, and it beat what analysts had expected by a wide margin (CNBC, Reuters). Profit was up roughly 77% from the same quarter a year earlier and rose over 23% from the prior quarter. Revenue reached NT$1,270.38 billion, up 12% from the previous quarter (TSMC Management Report). The company discussed its results on a call with investors on July 13, 2026.

TSMC also said it expects at least $44.6 billion in revenue for the third quarter (CNBC). And the company announced plans to invest an additional $100 billion in the United States (Reuters). The pledge comes as governments and companies push to make more advanced chips on U.S. soil rather than relying on factories abroad.

The size of the earnings beat matters. When a company this large grows profit by 77% in a year and revenue by double digits in a quarter, the main reason is that it can charge more for its most advanced chips — not just that it's making more of them. The Q3 revenue target of at least $44.6 billion, if reached, would continue a streak of rapid growth. Q1 revenue was already US$35.90 billion, up 40.6% from a year earlier (TSMC press release). In the first two months of 2026 alone, revenue totaled NT$718.91 billion, up 29.9% from the same period in 2025 (TSMC press release).

Chip Stocks Sell Off Despite the Print

The record results did not lift chip stocks. On July 16, 2026, the PHLX Semiconductor Index, which tracks major chip companies, fell 5%. The Nasdaq Composite slipped about 1% (WSJ). Sandisk, Western Digital, and Marvell were among the biggest losers. The drop was global: chip stocks fell across markets from Asia to the U.S., and companies tied to artificial intelligence dropped broadly (Reuters).

The weakness continued a pattern from the day before. On July 15, 2026, Micron Technology fell 8%, Lam Research dropped 3%, and AMD also declined (CNBC). That sell-off happened even as SK Hynix, a South Korean chip company, surged nearly 13% the same day on optimism about AI (Reuters). Another South Korean chip equipment maker, Hanmi, gained about 25% early in that session.

Think of it this way: if a company reports the best quarter in its history and its stock price falls anyway, the problem isn't the results — it's what investors had already priced in. The AI investing story has swung back and forth for weeks. The Wall Street Journal called it a "historic rally" on May 31 (WSJ). By July 7, the Journal reported a retreat on "worries about AI trade" (WSJ). Two days later, investors jumped back in and tech stocks rallied (WSJ). SK Hynix's U.S. stock market debut on July 10, priced at $149 and opening 14% higher, was described as the AI trade passing "another test" (Reuters, WSJ). By July 13, stocks fell again (WSJ).

The deeper question is whether investors are starting to doubt how long the AI spending boom can last. When a company beats expectations by T$74 billion and its sector still falls 5%, people are asking something different: not whether profits are good today, but whether the huge spending on AI infrastructure will pay off fast enough. TSMC's $100 billion U.S. investment pledge adds to that spending. The more money companies pour into building chip factories, the more revenue they need to earn to make that spending worthwhile. TSMC's Q3 revenue target of at least $44.6 billion is the number to watch. If growth slows from there, the gap between what companies are spending and what they're earning narrows — and markets are already worried about that.

UnitedHealth Group Raises 2026 Guidance

UnitedHealth Group, the largest health insurance company in the U.S., reported Q2 2026 revenues of $112.0 billion, earnings from operations of $8.0 billion, and earnings of $6.04 per share. It raised its outlook for the full year (UnitedHealth Group). The announcement came before markets opened on July 16. UnitedHealth's stock traded at $423.88 at midday.

The contrast with the tech world is striking. UnitedHealth brings in $112 billion a quarter, earns a steady profit, and felt confident enough to raise its forecast. That is a very different picture from chip companies whose stocks are swinging with every shift in AI sentiment. Whether there's a direct connection between the two — investors moving money from tech into healthcare — is possible but unproven.